Clinical Trials Logo

Degenerative Arthritis clinical trials

View clinical trials related to Degenerative Arthritis.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05441462 Completed - Clinical trials for Inflammatory Arthritis

Kinematics of Silastic Joint Replacements in the Hand

Start date: April 7, 2022
Phase:
Study type: Observational

To assess in vivo the kinematics of single piece silastic joint replacements in the hand with magnetic resonance imaging

NCT ID: NCT04815070 Completed - Clinical trials for Degenerative Arthritis

Gastric Volume in Diabetic Patients Undergoing Staged Bilateral Total Knee Arthroplasty

Start date: March 29, 2021
Phase:
Study type: Observational

Aspiration of gastric contents during perioperative period is a grave complication with significant morbidity and mortality. Diabetic patients have a higher incidence of autonomic dysfunction, causing gastropathy. They are known to have gastroparesis and the consequent delayed gastric emptying which predisposes them to an increased risk of aspiration than the general population. Furthermore, other common factors can influence the gastric emptying rate, as for example, old age, pain, and the use of opioid analgesics. In the previous study, evidence of increased pain was reported in patients undergoing staged bilateral total knee arthroplasty, in whom the second operated knee had greater sensitivity (tertiary hyperalgesia) due to the surgical injury to the first operated knee. In the present study, we will evaluate the effect of old age, diabetes, surgical stress, pain, and the use of analgesics on the residual gastric volume in elderly patients undergoing staged-bilateral total knee arthroplasty.

NCT ID: NCT04206150 Completed - Clinical trials for Degenerative Arthritis

The Appropriate Level of Continuous Adductor Canal Block in Patients Undergoing Total Knee Arthroplasty (TKA)

Start date: April 2, 2020
Phase: N/A
Study type: Interventional

Adductor canal catheters are being used to provide continuous postoperative analgesia after total knee arthroplasty surgery (TKA). There is much debate about where is the best position of continuous adductor canal block in patients undergoing TKA. Therefore, the investigators aim to compare the postoperative pain at three different level of continuous adductor canal block. Ninety six patients scheduled for total knee arthroplasty will be randomly divided into the three groups. In group 1, the adductor canal catheter is inserted at femoral triangle apex (the proximal end of the adductor canal). In group 2, the adductor canal catheter is inserted femur length/15*2 cm above the location where the nerve block performed in group 1. In group 3, the adductor canal catheter is inserted femur length/15cm below the location where the nerve block performed in group 1.

NCT ID: NCT03990805 Completed - Knee Osteoarthritis Clinical Trials

A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis

Start date: June 11, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the efficacy and safety of autologous Adipose Tissue derived Mesenchymal stem cells (JOINTSTEM®) in patient with severe Knee Osteoarthritis.

NCT ID: NCT03000712 Completed - Knee Osteoarthritis Clinical Trials

Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC Comared to Negative Control After High Tibial Osteotomy in the Osteoarthritis Patients.

Start date: November 2, 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of intra-articular injection of autologous adipose tissue derived mesenchymal stem cells compared after high tibial osteotomy to negative control in the osteoarthritis patients

NCT ID: NCT02658344 Completed - Knee Osteoarthritis Clinical Trials

Clinical Trial to Evaluate Efficacy and Safety of JOINTSTEM in Patients With Degenerative Arthritis

Start date: July 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate the efficacy and safety of autologous transplantation of Adipose Tissue derived Mesenchymal stem cells (MSCs) in patient with Knee Osteoarthritis.

NCT ID: NCT02341391 Completed - Clinical trials for Degenerative Arthritis

Safety and Biological Efficacy Study of TisssueGene-C to Degenerative Arthritis

Start date: February 2007
Phase: Phase 1
Study type: Interventional

The primary purpose of the this study is to evaluate the safety of TissueGene-C, a gene therapy product that uses allogenic human chondrocytes expressing Transforming Growth Factor(TGF)-β1 by assessing the inflammation at the injection site, the incidence and severity of the adverse events, the physical examination findings, and the laboratory test results after the intra-articular injection of TissueGene-C. And Secondary purpose is to evaluate the biological efficacy (knee pain, range of motion, functional tests, and MRI) of TissueGene-C and the distribution of TissueGene-C outside the injection site.

NCT ID: NCT02341378 Completed - Clinical trials for Degenerative Arthritis

Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis

Start date: August 2009
Phase: Phase 2
Study type: Interventional

To assess the efficacy and safety of the intra-articular injection of TissueGene-C in patients with degenerative arthritis of the knee

NCT ID: NCT02072070 Completed - Clinical trials for Degenerative Arthritis

Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis

Start date: November 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether TissueGene-C, an allogeneic human chondrocytes expressing Transforming Growth Factor(TGF)-b1, is effective and safe in patients with degenerative arthritis.

NCT ID: NCT01825811 Completed - Clinical trials for Degenerative Arthritis

Efficacy and Safety Study of TissueGene-C Mixed With Fibrin-glue for the Patients With Degenerative Arthritis

Start date: October 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether TissueGene-C, allogeneic human chondrocytes expressing Transforming Growth Factor(TGF)-b1, mixed with fibrin-glue is effective and safe in patients with degenerative arthritis.